Literature DB >> 1336965

Positive imaging of cardiomyopathy with 99mTc(V)-DMSA.

H Ohta1, T Komibuchi, S Kawamata, K Yamamoto, M Shichirousako, T Wada, H Kotoura, K Shizuki, K Endo, J Konishi.   

Abstract

A case of histologically proven dilated cardiomyopathy and a case of clinically diagnosed cardiomyopathy (cardiac amyloidosis was strongly suspected but was not confirmed) were examined with 99mTc(V)-dimercaptosuccinic acid (DMSA). 99mTc(V)-DMSA accumulation in the damaged myocardium was clearly demonstrated. These results suggested the possibility that 99mTc(V)-DMSA could be used as a positive agent for cardiomyopathy.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1336965     DOI： 10.1007/bf03164665

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN： 0914-7187            Impact factor:   2.668


  4 in total

1.  Tc-99m(V) DMSA uptake in cardiac amyloidosis.

Authors:  H Ohta; T Okada; Y Furukawa; K Yamamoto; Y Miyaki; K Shizuki; H Kotoura; K Endo; J Konishi; C Ohshima
Journal:  Clin Nucl Med       Date:  1991-09       Impact factor: 7.794

2.  Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP.

Authors:  D A Wulfrank; K H Schelstraete; F Small; C J Fallais
Journal:  Clin Nucl Med       Date:  1989-08       Impact factor: 7.794

3.  A new imaging agent for medullary carcinoma of the thyroid.

Authors:  H Ohta; K Yamamoto; K Endo; T Mori; D Hamanaka; A Shimazu; K Ikekubo; K Makimoto; Y Iida; J Konishi
Journal:  J Nucl Med       Date:  1984-03       Impact factor: 10.057

4.  Clinical evaluation of tumour imaging using 99Tc(V)m dimercaptosuccinic acid, a new tumour-seeking agent.

Authors:  H Ohta; K Endo; T Fujita; J Konishi; K Torizuka; K Horiuchi; A Yokoyama
Journal:  Nucl Med Commun       Date:  1988-02       Impact factor: 1.690
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.